Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study

BACKGROUND: Monoclonal antibodies (mABs) targeting the calcitonin gene-related peptide (CGRP) pathway represent the first disease-specific preventive migraine therapy. Growing evidence suggests that they are effective in the preventive treatment of difficult-to-treat patients. In this study, we eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Sara, Bottiroli, De Icco, Roberto, Vaghi, Gloria, Pazzi, Stefania, Guaschino, Elena, Allena, Marta, Ghiotto, Natascia, Martinelli, Daniele, Tassorelli, Cristina, Sances, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487575/
https://www.ncbi.nlm.nih.gov/pubmed/34600468
http://dx.doi.org/10.1186/s10194-021-01333-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487575/
https://www.ncbi.nlm.nih.gov/pubmed/34600468
http://dx.doi.org/10.1186/s10194-021-01333-4

Ejemplares similares